Therapeutic Area | MeSH |
---|---|
cardiovascular diseases | D002318 |
nutritional and metabolic diseases | D009750 |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
LIPOFEN | Cipher Pharmaceuticals | N-021612 RX | 2006-01-11 | 2 products, RLD, RS |
ANTARA (MICRONIZED) | Lupin Research | N-021695 RX | 2004-11-30 | 2 products, RLD, RS |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
SOLUPREP S | 3M | N-208288 OTC | 2018-08-08 | 1 products, RLD, RS |
CHLORAPREP ONE-STEP | BD | N-020832 OTC | 2000-07-14 | 1 products, RLD, RS |
CHLORAPREP WITH TINT | BD | N-020832 OTC | 2005-05-03 | 1 products, RLD, RS |
CHLORAPREP ONE-STEP FREPP | BD | N-020832 OTC | 2002-04-26 | 1 products, RLD, RS |
CHLORAPREP ONE-STEP | BD | N-020832 OTC | 2003-08-20 | 1 products, RLD, RS |
CHLORAPREP WITH TINT | BD | N-020832 OTC | 2006-04-03 | 1 products, RLD, RS |
CHLORAPREP ONE-STEP | BD | N-020832 OTC | 2006-11-21 | 1 products, RLD, RS |
CHLORAPREP WITH TINT | BD | N-020832 OTC | 2006-10-10 | 1 products, RLD, RS |
CHLORAPREP ONE-STEP | BD | N-020832 OTC | 2008-10-23 | 1 products, RLD, RS |
CHLORAPREP ONE-STEP SEPP | BD | N-021555 OTC | 2002-10-07 | 1 products, RLD, RS |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
ZURAGARD | Zurex Pharma | N-210872 OTC | 2019-04-26 | 1 products, RLD, RS |
Brand Name | Status | Last Update |
---|---|---|
antara | New Drug Application | 2024-08-20 |
fenofibrate | ANDA | 2025-02-20 |
fenoglide | New Drug Application | 2011-05-13 |
lipofen | New Drug Application | 2021-09-21 |
tricor | New Drug Application | 2024-11-14 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Dyslipidemias | D050171 | — | — | 6 | 13 | 16 | 11 | 7 | 48 |
Hypertriglyceridemia | D015228 | EFO_0004211 | — | 1 | 5 | 9 | 10 | 6 | 31 |
Hyperlipidemias | D006949 | EFO_0003774 | E78.5 | 1 | 2 | 14 | 8 | 5 | 30 |
Hyperlipoproteinemias | D006951 | — | — | — | 1 | 12 | 7 | 3 | 23 |
Infections | D007239 | EFO_0000544 | — | 2 | — | 4 | 7 | 8 | 21 |
Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | — | 2 | 6 | 5 | 6 | 18 |
Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | — | 2 | 4 | 4 | 8 | 18 |
Surgical wound infection | D013530 | — | — | 1 | 2 | 4 | 5 | 4 | 16 |
Metabolic syndrome | D024821 | EFO_0000195 | E88.810 | — | 3 | 1 | 3 | 8 | 15 |
Communicable diseases | D003141 | — | — | 1 | — | 4 | 5 | 5 | 15 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Biliary liver cirrhosis | D008105 | — | K74.3 | 2 | 6 | 8 | — | — | 12 |
Cholangitis | D002761 | HP_0030151 | K83.0 | 2 | 4 | 6 | — | — | 8 |
Vomiting | D014839 | — | R11.1 | 1 | 1 | 1 | — | 3 | 5 |
Glucose metabolism disorders | D044882 | — | — | — | 1 | 4 | — | — | 4 |
Metabolic diseases | D008659 | EFO_0000589 | E88.9 | — | 1 | 4 | — | — | 4 |
Liver cirrhosis | D008103 | EFO_0001422 | K74.0 | — | 2 | 2 | — | — | 4 |
Fibrosis | D005355 | — | — | — | 2 | 2 | — | — | 4 |
Diabetic nephropathies | D003928 | EFO_0000401 | — | — | 1 | 2 | — | — | 3 |
Kidney diseases | D007674 | EFO_0003086 | N08 | 1 | — | 2 | — | — | 3 |
Type 1 diabetes mellitus | D003922 | EFO_0001359 | E10 | — | 2 | 1 | — | — | 3 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 14 | 1 | — | — | 6 | 21 |
Non-alcoholic fatty liver disease | D065626 | EFO_0003095 | K75.81 | 1 | 3 | — | — | 3 | 7 |
Fatty liver | D005234 | EFO_0003934 | — | 1 | 3 | — | — | 3 | 7 |
Liver diseases | D008107 | EFO_0001421 | K70-K77 | — | 3 | — | — | 3 | 6 |
Inflammation | D007249 | MP_0001845 | — | — | 1 | — | — | 2 | 3 |
Neoplasms | D009369 | — | C80 | 1 | 1 | — | — | 1 | 3 |
Weight loss | D015431 | — | — | — | 1 | — | — | 1 | 2 |
Overweight | D050177 | — | E66.3 | — | 2 | — | — | — | 2 |
Multiple myeloma | D009101 | — | C90.0 | — | 1 | — | — | 1 | 2 |
Plasma cell neoplasms | D054219 | — | — | — | 1 | — | — | 1 | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Bacterial infections | D001424 | — | A49 | 1 | — | — | — | — | 1 |
Gram-negative bacterial infections | D016905 | — | — | 1 | — | — | — | — | 1 |
Infertility | D007246 | EFO_0000545 | — | 1 | — | — | — | — | 1 |
Rotavirus infections | D012400 | — | — | 1 | — | — | — | — | 1 |
Depressive disorder | D003866 | EFO_1002014 | F32.A | 1 | — | — | — | — | 1 |
Carcinoma in situ | D002278 | — | D09.9 | 1 | — | — | — | — | 1 |
Uterine cervical dysplasia | D002578 | EFO_1000910 | N87 | 1 | — | — | — | — | 1 |
Chronic renal insufficiency | D051436 | — | N18 | 1 | — | — | — | — | 1 |
Renal insufficiency | D051437 | — | N19 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Diabetes complications | D048909 | — | — | — | — | — | — | 2 | 2 |
Vascular diseases | D014652 | EFO_0004264 | I77 | — | — | — | — | 2 | 2 |
Radiodermatitis | D011855 | — | L58 | — | — | — | — | 2 | 2 |
Malnutrition | D044342 | EFO_0008572 | E40-E46 | — | — | — | — | 2 | 2 |
Thrombosis | D013927 | — | — | — | — | — | — | 2 | 2 |
Myofascial pain syndromes | D009209 | EFO_1001054 | — | — | — | — | — | 2 | 2 |
Bites and stings | D001733 | — | — | — | — | — | — | 2 | 2 |
Schizophrenia | D012559 | EFO_0000692 | F20 | — | — | — | — | 1 | 1 |
Cytokinesis | D048749 | — | — | — | — | — | — | 1 | 1 |
Vitamin d deficiency | D014808 | EFO_0003762 | E55 | — | — | — | — | 1 | 1 |
Drug common name | Fenofibrate |
INN | fenofibrate |
Description | Fenofibrate is a chlorobenzophenone that is (4-chlorophenyl)(phenyl)methanone substituted by a [2-methyl-1-oxo-1-(propan-2-yloxy)propan-2-yl]oxy group at position 1 on the phenyl ring. It has a role as an antilipemic drug, an environmental contaminant, a xenobiotic and a geroprotector. It is a chlorobenzophenone, a member of monochlorobenzenes, an aromatic ether and an isopropyl ester. It is functionally related to a benzophenone. |
Classification | Small molecule |
Drug class | antihyperlipidemics (clofibrate type) |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | CC(C)OC(=O)C(C)(C)Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1 |
PDB | — |
CAS-ID | 49562-28-9 |
RxCUI | — |
ChEMBL ID | CHEMBL672 |
ChEBI ID | 5001 |
PubChem CID | 3339 |
DrugBank | DB01039 |
UNII ID | U202363UOS (ChemIDplus, GSRS) |